Better deal strategy starts with an honest diagnosis.

WinSignal is building The Deal Autopsy: an AI-powered approach to understanding why complex B2B opportunities stall, slip, or disappear into no decision.

We help enterprise sales teams make the hidden decision system visible— the buying committee, competitive pressure, internal alternatives, evidence gaps, and assumptions that conventional pipeline reviews miss.

Our mission is simple: replace vague deal optimism with clear reasoning and specific action. Alongside private assessments and live reviews, anonymized Deal Autopsies share practical lessons from how real B2B deals are won and lost.